TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update

Go back to TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 8.61 +0.96 (12.55%)
Previous Close $7.65    52 Week High
Open $7.74    52 Week Low
Day High $8.79    P/E N/A 
Day Low $7.62    EPS
Volume 51,709